Leukemia
A Phase 2 Study of WU-CART-007, an Anti-CD7 Allogeneic CAR-T Cell Therapy, in Patients with Relapsed or Refractory T Cell Acute Lymphoblastic Leukemia and Lymphoblastic Lymphoma (T-RRex)
- Details
ClinicalTrials.gov ID:
NCT06514794
Diagnosis Type:
NA
USOR Number:
- Address
,
P: